Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(43%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
14%
Ph phase_1
1
14%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Completed(2)
Terminated(1)

Detailed Status

Completed2
Recruiting2
Withdrawn1
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

withdrawn114%
completed229%
not_yet_recruiting114%
active_not_recruiting114%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7